The healthcare innovation services provider has joined forces with Tikehau Capital for a fund called TKS1 that has reached its first close.
Healthcare technology services provider Sprim launched a Singapore-based venture capital initiative yesterday in partnership with asset management firm Tikehau Capital with $50m of capital.
Sprim’s participation in the fund, dubbed TKS1, will be conducted by its local corporate venturing unit, Sprim Ventures. The $50m figure represents its initial close.
TKS1 will provide between $500,000 and $5m for early-stage life science and medical technology developers, and has already made investments in five portfolio companies.
The companies in question include infant milk…